Tenofovir Disoproxil Fumarate Tablet
Product Images NDC 69097-533
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tenofovir Disoproxil Fumarate (NDC 69097-533). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
6c2c9baa Dd0d 4380 8cdf F6b4d542e079 02
Each tablet contains Tenofovir Isoproxil Fumarate 500mg equivalent to 245mg of Tenofovir Disoproxil. The tablets are film-coated and are available only on prescription. It is recommended to refer to the package insert for dosages and administration. The tablets should be stored in a closed container at 20°C to 25°C or 68°F to 77°F. The tablets are manufactured by Cipla Ltd. in Verna, Goa, India, and distributed by Cipla USA, Inc. in Warren, NJ. The details for batch information printing can be found in a designated area of the packet.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.